Key result
The authors argue that delaying risk stratification by five to seven weeks after myocardial infarction fails to identify patients at highest early risk of adverse cardiac events.
This collection of letters to the editor debates various medical topics, including a discussion concluding that the routine addition of heparin to aspirin in acute myocardial infarction is not justified by current trial evidence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Archbold et al. (1997) conducted a letter in Myocardial infarction. The authors argue that delaying risk stratification by five to seven weeks after myocardial infarction fails to identify patients at highest early risk of adverse cardiac events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: